Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
-
19541
Data_Sheet_1_Mapping of a Regulatory Site of the Escherichia coli ADP-Glucose Pyrophosphorylase.PDF
Published 2019“…Other potent activator analogs include 1,6-hexanediol bisphosphate (HBP) and pyridoxal 5′-phosphate (PLP). Recently, a crystal structure with FBP bound was reported (PDB ID: 5L6S). …”
-
19542
-
19543
-
19544
-
19545
Datasheet1_Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)...
Published 2022“…Notably, 3 of 5 patients (60%) with normal VWF:Ac/VWF:Ag ratio >0.7 had abnormal VWF multimers, indicating AVWS type 2. …”
-
19546
-
19547
(a) As the condensate is being squeezed in the <em>xy</em> plane, the peak value of the mathcal {F}_z increases with respect to ω<sub>⊥</sub>/ω, where ω<sub>⊥</sub> is the trapping...
Published 2013“…<p><strong>Figure 5.</strong> (a) As the condensate is being squeezed in the <em>xy</em> plane, the peak value of the \mathcal {F}_z increases with respect to ω<sub>⊥</sub>/ω, where ω<sub>⊥</sub> is the trapping frequency in the squeezing direction. …”
-
19548
-
19549
Structure and Bonding Properties of the Complex (η<sup>5</sup>-Diphenylfulvene)Mn(CO)<sub>3</sub><sup>+</sup>
Published 2000“…As a result of the bending of the exo methylene group the positive charge at the metal is increased and at C9 decreased.…”
-
19550
Reduced Long-Term Relative Survival in Females and Younger Adults Undergoing Cardiac Surgery: A Prospective Cohort Study
Published 2016“…The observed 30-day, 1-, 3- and 5-year mortality rates were 2.2%, 4.4%, 8.2% and 13.8%, respectively, and remained constant throughout the study period. …”
-
19551
Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives
Published 2010“…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
-
19552
Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives
Published 2010“…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
-
19553
Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives
Published 2010“…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
-
19554
Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives
Published 2010“…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
-
19555
Metallization of a Hypervalent Radical Dimer: Molecular and Band Perspectives
Published 2010“…Variable pressure and temperature conductivity measurements on the bisthiaselenazolyl radical dimer [<b>1a</b>]<sub>2</sub> have established the presence of a weakly metallic state over the pressure range 5−9 GPa. …”
-
19556
-
19557
-
19558
Table_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
-
19559
Image_2_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.tif
Published 2022“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”
-
19560
Table_4_NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer.docx
Published 2022“…</p>Results<p>To the best to our knowledge, we present for the first time an overview of the genomic mutation spectrum of early-stage laryngeal cancers. A total of 469 genomic alterations were detected in 211 distinct cancer-relevant genes, and the genes found to be mutated in more than five patients (>10%) included tumor protein p53 (TP53, 78.5%), FAT atypical cadherin 1 (FAT1, 26%), LDL receptor related protein 1B (LRP1B, 19%), cyclin dependent kinase inhibitor 2A (CDKN2A, 17%), tet methylcytosine dioxygenase 2 (TET2, 17%), notch receptor 1 (NOTCH1, 12%) and neuregulin 1 (NRG1, 12%). …”